The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of ruxolitinib in patients (pts) with myeloproliferative neoplasms (MPNs) treated off clinical trial.
 
Kiran Naqvi
No Relationships to Disclose
 
Sherry Pierce
No Relationships to Disclose
 
Lingsha Zhou
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Jorge E. Cortes
No Relationships to Disclose
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Srdan Verstovsek
No Relationships to Disclose